Prochlorperazine dimaleate salt
SIGMA/P9178
CAS Number: 84-02-6
Empirical Formula (Hill Notation): C20H24ClN3S · 2C4H4O4
Molecular Weight: 606.09
EC Number: 201-511-3
MDL Number: MFCD00069330
Linear Formula: C20H24ClN3S · 2C4H4O4
Product Type: Chemical
| form | powder |
| InChI | 1S/C20H24ClN3S.2C4H4O4/c1 |
| InChI key | DSKIOWHQLUWFLG-SPIKMXEPSA |
| originator | GlaxoSmithKline |
| Quality Level | 200 ![]() |
| SMILES string | OC(=O)C=C/C(O)=O.OC(=O) |
| solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclode |
| H2O: slightly soluble 0.3 mg/mL | |
| methanol: soluble |
| Biochem/physiol Actions: | Phenothiazine antipsychotic; D2 dopamine receptor antagonist; antispasmodic |
| Biochem/physiol Actions: | Prochlorperazine is an anti-nausea and neuroleptic agent. It is known to cause neuropsychiatric side effects. Prochlorperazine inhibits the action of dopamine in the central nervous system. It acts as an antiemetic drug and prevents vomiting and stimulates sleep. Prochlorperazine is useful as a tranquilizer in the treatment of schizophrenia and nonpsychotic anxiety. |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5 g in poly bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H302 - H336 - H361d - H362 |
| Precautionary statements | P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| UNSPSC | 41116107 |



